Fujian Wanchen Biotechnology Group Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 9,293.74 million compared to CNY 549.26 million a year ago. Net loss was CNY 82.93 million compared to net income of CNY 47.74 million a year ago.

Basic loss per share from continuing operations was CNY 0.5395 compared to basic earnings per share from continuing operations of CNY 0.311 a year ago. Diluted loss per share from continuing operations was CNY 0.5395 compared to diluted earnings per share from continuing operations of CNY 0.3077 a year ago.